ArticleAustralasian journal on ageing2025
Deprescribing in Australian residential aged care facilities: A scoping review.
Article in Australasian journal on ageing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deprescribing in Australian residential aged care facilities: A scoping review.Australasian journal on ageing · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesOlder adults residing in residential aged care facilities (RACFs) are particularly vulnerable to negative health outcomes from polypharmacy and suboptimal prescribing in the context of frailty and multimorbidity. Deprescribing, the intentional withdrawal of inappropriate medications, has been proposed as a promising approach to reduce polypharmacy-related harms. Examining current deprescribing interventions in RACFs would help identify gaps in research knowledge. The aim of this scoping review was to synthesise the current literature, describe the current knowledge gaps and future research priorities that the authors identified.
methodsMEDLINE, Embase, CINAHL, PsycINFO and AgeLine were searched according to the Joanna Briggs Institute (JBI) guidelines for scoping reviews from inception until February 2024 to identify relevant studies published in the English language.
resultsOf the 2244 articles screened, 13 studies (total of 133,150 RACF residents across Australia) were identified examining deprescribing interventions. Six studies were controlled trials and seven studies were observational studies. There were six pharmacist-led interventions, five multidisciplinary team-led interventions and two physician-led interventions. Main themes discussed included as follows: multidisciplinary care, education for health-care professionals, refining outcome measures, overcoming system issues and research logistics. The most commonly targeted medications in the included studies were psychotropics.
conclusionsDeprescribing is an important intervention for RACF residents but more research into translating evidence into clinically meaningful outcomes is needed. Successful studies typically involved multidisciplinary interventions, had an educational component, followed-up longitudinally with residents and carers and involved stakeholders, such as nurses. The economic impacts of deprescribing in this cohort are poorly understood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.